We are live on !
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
Turnover
40.17%
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow % of AUM
Cap. Flow %
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Avg Time Held
Equity + Options
1
year
Top 10 Avg Time Held
Equity + Options
2.3
years
Top 20 Avg Time Held
Equity + Options
1.6
years
Avg Time Held Equity only
1
year
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.9B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2276
Bankunited
BKU
$3.07B
| $828K | ﹤0.01% |
17,086
-19,052
| -53% | -$896K |
2026 Q1
1 quarter
|
|
2277
Chemung Financial Corp
CHMG
$412M
| $828K | ﹤0.01% |
+11,097
| New | +$744K |
2026 Q2
0 quarters
|
|
2278
ING
ING
$91.8B
| $823K | ﹤0.01% |
26,228
-26,505
| -50% | -$784K |
2026 Q1
1 quarter
|
|
2279
Telephone and Data Systems
TDS
$4.11B
| $822K | ﹤0.01% |
22,216
+7,209
| +48% | +$304K |
2026 Q1
1 quarter
|
|
2280
CALL
Biogen
BIIB
$37.3B
| $821K | ﹤0.01% |
3,800
-2,600
| -41% | -$497K |
2025 Q3
3 quarters
|
|
2281
Barrett Business Services
BBSI
$808M
| $820K | ﹤0.01% |
23,079
-2,620
| -10% | -$82.3K |
2026 Q1
1 quarter
|
|
2282
Brightstar Lottery PLC
BRSL
$1.74B
| $814K | ﹤0.01% |
75,960
+16,800
| +28% | +$200K |
2025 Q3
3 quarters
|
|
2283
VanEck Pharmaceutical ETF
PPH
$1.06B
| $809K | ﹤0.01% |
7,398
-9,646
| -57% | -$998K |
2025 Q3
3 quarters
|
|
2284
Haleon
HLN
$44.9B
| $808K | ﹤0.01% |
86,582
-184,992
| -68% | -$1.72M |
2026 Q1
1 quarter
|
|
2285
Robert Half
RHI
$4.6B
| $807K | ﹤0.01% |
26,298
-189,448
| -88% | -$5.31M |
2025 Q4
2 quarters
|
|
2286
Invesco S&P 500 Pure Value ETF
RPV
$1.74B
| $807K | ﹤0.01% |
+7,092
| New | +$792K |
2026 Q2
0 quarters
|
|
2287
York Space Systems
YSS
$868M
| $800K | ﹤0.01% |
+32,513
| New | +$1.01M |
2026 Q2
0 quarters
|
|
2288
Prime Medicine
PRME
$655M
| $800K | ﹤0.01% |
216,841
+74,884
| +53% | +$249K |
2026 Q1
1 quarter
|
|
2289
Connect Biopharma Holdings
CNTB
$53.5M
| $799K | ﹤0.01% |
335,642
+269,629
| +408% | +$654K |
2025 Q3
3 quarters
|
|
2290
Runway Growth Finance
RWAY
$267M
| $796K | ﹤0.01% |
141,904
-208,815
| -60% | -$1.32M |
2024 Q4
6 quarters
|
|
2291
NRX Pharmaceuticals
NRXP
$110M
| $796K | ﹤0.01% |
+194,580
| New | +$643K |
2026 Q2
0 quarters
|
|
2292
JD.com
JD
$34.1B
| $795K | ﹤0.01% |
31,212
-718
| -2% | -$21.2K |
2023 Q3
11 quarters
|
|
2293
CALL
Humana
HUM
$50.1B
| $794K | ﹤0.01% |
2,000
-200
| -9% | -$56.9K |
2025 Q3
3 quarters
|
|
2294
Sunshine Silver Mining & Refining Company
SSMR
$1.88B
| $794K | ﹤0.01% |
+60,092
| New | +$850K |
2026 Q2
0 quarters
|
|
2295
Gladstone Land Corp
LAND
$383M
| $793K | ﹤0.01% |
+92,933
| New | +$888K |
2026 Q2
0 quarters
|
|
2296
Silence Therapeutics
SLN
$1.23B
| $791K | ﹤0.01% |
72,039
-97,577
| -58% | -$686K |
2024 Q1
9 quarters
|
|
2297
MiMedx Group
MDXG
$562M
| $789K | ﹤0.01% |
204,856
-1,656,290
| -89% | -$6.04M |
2025 Q2
4 quarters
|
|
2298
Isabella Bank
ISBA
$297M
| $785K | ﹤0.01% |
19,865
-33,813
| -63% | -$1.45M |
2025 Q4
2 quarters
|
|
2299
Shoulder Innovations Inc
SI
$403M
| $784K | ﹤0.01% |
+38,667
| New | +$594K |
2026 Q2
0 quarters
|
|
2300
Evertec
EVTC
$1.85B
| $782K | ﹤0.01% |
28,132
-33,971
| -55% | -$903K |
2025 Q1
5 quarters
|
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.9B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.